TauC3 Biologics is focused on the development of innovative high precision immunotherapy for the treatment of the devastating neurodegenerative diseases known as tauopathies, particularly tau-related frontotemporal dementia (FTD-tau) and progressive supranuclear palsy (PSP).

Contact: Daniel G. Chain, PhD, President and CEO
dchain@tauc3bio.com